Literature DB >> 2011804

Lupus nephritis. Part I. Histopathological classification, activity and chronicity scores.

W D Bates1, A M Halland, R D Tribe, D J Rossouw.   

Abstract

Renal biopsy has made a major contribution to the understanding and management of patients with lupus nephritis. In a 5-year retrospective study the renal morphology of 55 biopsies from 51 patients with lupus nephritis was classified according to World Health Organisation criteria. In addition, semi-quantitative activity and chronicity scores were documented. The findings were similar to series from other parts of the world. Of the biopsies reviewed, 6 were class II, 13 class III, 32 class IV and 4 class V. In situations of overlap, segmental proliferative features determined the class to which a biopsy specimen was assigned. Twenty-five of the patients, all WHO class IV, showed activity scores in the severe range. Most of the activity score features were common and easily recognised but necrotising angiitis was only seen in 1 patient. Haematoxylin bodies were difficult to document and the nature and value of the haematoxylin body is questioned.

Entities:  

Mesh:

Year:  1991        PMID: 2011804

Source DB:  PubMed          Journal:  S Afr Med J


  3 in total

1.  Survival of patients with SLE admitted to an intensive care unit-a retrospective study.

Authors:  D A Whitelaw; R Gopal; V Freeman
Journal:  Clin Rheumatol       Date:  2004-11-25       Impact factor: 2.980

2.  The effect of immunosuppressive therapy in patients with fibrinoid necrosis lesions in a large cohort of patients with IgA nephropathy.

Authors:  Yingman Guo; Sufang Shi; Xujie Zhou; Lijun Liu; Jicheng Lv; Li Zhu; Suxia Wang; Hong Zhang
Journal:  J Nephrol       Date:  2021-10-21       Impact factor: 3.902

3.  TGF-β-Induced CD8+CD103+ Regulatory T Cells Show Potent Therapeutic Effect on Chronic Graft-versus-Host Disease Lupus by Suppressing B Cells.

Authors:  Haowen Zhong; Ya Liu; Zhenjian Xu; Peifeng Liang; Hui Yang; Xiao Zhang; Jun Zhao; Junzhen Chen; Sha Fu; Ying Tang; Jun Lv; Julie Wang; Nancy Olsen; Anping Xu; Song Guo Zheng
Journal:  Front Immunol       Date:  2018-01-30       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.